Sujata Mohanty

This study shows that hypoxia-primed Wharton's jelly MSC-derived sEVs improve behavioral and neuroinflammatory outcomes in a mouse model of ASD through enhanced neuroprotective effects.

This study generates iPSC models of MLC by reprogramming patient-derived cells and gene editing, revealing disease-specific vacuolation in astrocytes and differentially expressed genes related to neurological disorders.

This study optimizes the dose and timing of MSC-derived culture-conditioned media (CCM) to enhance its immunomodulatory effects on CD3+ T-cells in acute graft-versus-host disease.

This study compares the immunomodulatory and antioxidant effects of apoptotic and viable sEVs from bone marrow and Wharton's jelly MSCs in an in vitro liver injury model.

This paper identifies a probiotic enzyme that converts cholesterol to coprostanol and links its abundance to diabetes.

This study evaluates dexamethasone-primed mesenchymal stem cell conditioned media for treating SLE, showing improved immunomodulation and organ protection compared to standard therapies.

This study compares the immunomodulatory effects of hypoxia-preconditioned bone marrow and Wharton's jelly mesenchymal stem cells in acute graft-versus-host disease, finding WJ-MSCsHYP more effective due to enhanced mitochondrial transfer and metabolic reprogramming.

This study shows that hypoxia and apoptosis conditioning of WJ-MSCs enhances their immune regulatory capacity in aGVHD by promoting Treg differentiation and M2 macrophage polarization.

This study compares T-cell responses between healthy donors and aGVHD patients to optimize PHA and IL-2 concentrations for in vitro T-cell proliferation studies.